Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1
Goethe University Frankfurt · University Hospital Frankfurt · +13 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,185
total citations
- FWCI
- 66.46
- Percentile
- 100%
- References
- 52
Citations per year
Authors
27- MOMarion OttCorresponding
Goethe University Frankfurt, University Hospital Frankfurt
- MSManfred Schmidt
National Center for Tumor Diseases, University of Freiburg, University Medical Center Freiburg
- KSKerstin Schwarzwaelder
University of Freiburg, National Center for Tumor Diseases
- SSStefan Stein
Georg Speyer Haus
- USUlrich Siler
University Children's Hospital Zurich
Topics & keywords
Topics
Keywords
- Chronic granulomatous disease
- Myelopoiesis
- Genetic enhancement
- Haematopoiesis
- Myeloid
- Immunology
- Primary immunodeficiency
- Bone marrow
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.